loadpatents
name:-0.037227153778076
name:-0.012773990631104
name:-0.0014939308166504
ESCOBEDO; Jaime Patent Filings

ESCOBEDO; Jaime

Patent Applications and Registrations

Patent applications and USPTO patent grants for ESCOBEDO; Jaime.The latest application filed is for "endogenous retrovirus polypeptides linked to oncogenic transformation".

Company Profile
0.12.26
  • ESCOBEDO; Jaime - Alamo CA
  • Escobedo; Jaime - Emeryville CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Endogenous Retrovirus Polypeptides Linked To Oncogenic Transformation
App 20140135384 - GARCIA; Pablo ;   et al.
2014-05-15
Gene Products Differentially Expressed In Cancerous Cells
App 20120308569 - CHAN; Vivien W. ;   et al.
2012-12-06
Gene products differentially expressed in cancerous cells
Grant 8,221,983 - Chan , et al. July 17, 2
2012-07-17
Endogenous Retroviruses Up-regulated In Prostate Cancer
App 20110020352 - GARCIA; Pablo D. ;   et al.
2011-01-27
Gene Products Differentially Expressed In Cancerous Cells
App 20100233187 - Chan; Vivien W. ;   et al.
2010-09-16
Endogenous retroviruses up-regulated in prostate cancer
Grant 7,776,523 - Garcia , et al. August 17, 2
2010-08-17
Endogenous Retroviruses Up-regulated In Prostate Cancer
App 20100136522 - Garcia; Pablo D. ;   et al.
2010-06-03
Gene products differentially expressed in cancerous cells
Grant 7,700,359 - Chan , et al. April 20, 2
2010-04-20
Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)
App 20090170197 - Pavco; Pamela ;   et al.
2009-07-02
Human genes and gene expression products
App 20070243176 - Escobedo; Jaime ;   et al.
2007-10-18
Endogenous retrovirus polypeptides linked to oncogenic transformation
App 20070037147 - Garcia; Pablo ;   et al.
2007-02-15
Gene products differentially expressed in cancerous cells III
App 20070010469 - Chan; Vivien W. ;   et al.
2007-01-11
Endogenous retrovirus up-regulated in prostate cancer
App 20060275747 - Hardy; Stephen F. ;   et al.
2006-12-07
Human genes and gene expression products V
Grant 7,122,373 - Williams , et al. October 17, 2
2006-10-17
Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
Grant 7,034,009 - Pavco , et al. April 25, 2
2006-04-25
P-cadherin as a target for anti-cancer therapy
App 20060039915 - Reinhard; Christoph ;   et al.
2006-02-23
Human genes and gene expression products II
Grant 6,964,868 - Williams , et al. November 15, 2
2005-11-15
Gene products differentially expressed in cancerous cells and their methods of use II
App 20050227917 - Williams, Lewis T. ;   et al.
2005-10-13
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
Grant 6,818,447 - Pavco , et al. November 16, 2
2004-11-16
Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
App 20040102389 - Pavco, Pamela ;   et al.
2004-05-27
Human genes and gene expression products XVI
App 20040086913 - Williams, Lewis T. ;   et al.
2004-05-06
Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
App 20040077565 - Pavco, Pamela ;   et al.
2004-04-22
Human genes and gene expression products isolated from human prostate
App 20030215803 - Garcia, Pablo Dominguez ;   et al.
2003-11-20
P-cadherin as a target for anti-cancer therapy
App 20030194406 - Reinhard, Christoph ;   et al.
2003-10-16
Method of screening for factors that modulate gene expression
App 20030170656 - Cen, Hui ;   et al.
2003-09-11
Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectors
App 20030166284 - Srivastava, Arun ;   et al.
2003-09-04
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
Grant 6,566,127 - Pavco , et al. May 20, 2
2003-05-20
Novel human genes and gene expression products I
App 20030065156 - Williams, Lewis T. ;   et al.
2003-04-03
Human genes and gene expression products
App 20030044783 - Williams, Lewis T. ;   et al.
2003-03-06
AAV vectors
Grant 6,521,225 - Srivastava , et al. February 18, 2
2003-02-18
Replication-defective recombinant AAV virions
App 20020132336 - Dwarki, Varavani ;   et al.
2002-09-19
Diagnostic and therapeutic methods using molecules differentially expressed in cancer cells
App 20020076735 - Williams, Lewis T. ;   et al.
2002-06-20
Secreted human proteins
App 20020076761 - Escobedo, Jaime ;   et al.
2002-06-20
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
Grant 6,346,398 - Pavco , et al. February 12, 2
2002-02-12
Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectors
App 20010051611 - Srivastava, Arun ;   et al.
2001-12-13
Materials and methods for simplified AAV production
App 20010034054 - Dwarki, Varavani ;   et al.
2001-10-25
Materials and methods for simplified AAV production
Grant 6,221,646 - Dwarki , et al. April 24, 2
2001-04-24
Method and construct for screening for inhibitors of transcriptional activation
Grant 5,747,338 - Giese , et al. May 5, 1
1998-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed